drugset / Trial / NCT00717860
A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the safety and efficacy of MK0991 in patients with deep-seated mycoses.
Timeline
- Start
- 2008-08
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Caspofungin | Other / unclassified | 50 mg | Intravenous |
| Comparator | Micafungin | Peptide | 150 mg | Intravenous |